OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SELIC55

Selic Corp PCL

Specialty ChemicalsVerified

Selic Corp PCL maintains a debt-to-equity ratio of 0.85, indicating a moderate reliance on debt financing, while its current ratio of 1.26 suggests limited short-term liquidity cushion. The company's free cash flow of 67.083 million THB supports operational flexibility, though its operating cash flow of 68.288 million THB is constrained by capital expenditures of -21.136 million THB. With total liabilities of 2,077.7 million THB and total equity of 1,076.186 million THB, the company's capital structure reflects a conservative approach to leverage. The company's return on equity of 3.99% and return on assets of 1.36% fall below the typical performance benchmarks for the specialty chemicals industry, indicating suboptimal capital efficiency and asset utilization. Gross profit of 175.122 million THB on revenue of 560.061 million THB yields a gross margin of 31.27%, which is in line with industry norms but leaves room for improvement in cost control. Operating income of 96.27 million THB and net income of 42.892 million THB reflect a net margin of 7.66%, which is below the median for the sector. Selic Corp PCL's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial data. This lack of segment or geographic diversification increases exposure to sector-specific risks and regional economic fluctuations. The company's revenue concentration in a single segment suggests limited strategic flexibility in the face of market volatility. The company's growth trajectory is constrained by a lack of disclosed revenue growth in the latest period, with no clear indicators of expansion or market penetration in the near term. The absence of a defined growth strategy is compounded by a low dilution risk profile, as the company has not issued new shares recently and maintains a stable share count. The risk assessment highlights a key flag: net cash is negative after subtracting total debt, signaling potential liquidity constraints. Recent filings and transcripts do not disclose any material events or strategic initiatives that would significantly alter the company's financial trajectory in the near term. The company's financial disclosures remain consistent with its historical performance, with no indication of major operational or strategic shifts.

30-day price · SELIC+0.05 (+2.0%)
Low$2.34High$2.68Close$2.62As of12 May, 00:00 UTC
Profile
CompanySelic Corp PCL
TickerSELIC.BK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Selic Corp PCL is a specialty chemicals company that produces and distributes chemical products for industrial applications, generating revenue primarily through the sale of chemical compounds and related services.

Classification. Selic Corp PCL is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Selic Corp PCL maintains a debt-to-equity ratio of 0.85, indicating a moderate reliance on debt financing, while its current ratio of 1.26 suggests limited short-term liquidity cushion. The company's free cash flow of 67.083 million THB supports operational flexibility, though its operating cash flow of 68.288 million THB is constrained by capital expenditures of -21.136 million THB. With total liabilities of 2,077.7 million THB and total equity of 1,076.186 million THB, the company's capital structure reflects a conservative approach to leverage. The company's return on equity of 3.99% and return on assets of 1.36% fall below the typical performance benchmarks for the specialty chemicals industry, indicating suboptimal capital efficiency and asset utilization. Gross profit of 175.122 million THB on revenue of 560.061 million THB yields a gross margin of 31.27%, which is in line with industry norms but leaves room for improvement in cost control. Operating income of 96.27 million THB and net income of 42.892 million THB reflect a net margin of 7.66%, which is below the median for the sector. Selic Corp PCL's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial data. This lack of segment or geographic diversification increases exposure to sector-specific risks and regional economic fluctuations. The company's revenue concentration in a single segment suggests limited strategic flexibility in the face of market volatility. The company's growth trajectory is constrained by a lack of disclosed revenue growth in the latest period, with no clear indicators of expansion or market penetration in the near term. The absence of a defined growth strategy is compounded by a low dilution risk profile, as the company has not issued new shares recently and maintains a stable share count. The risk assessment highlights a key flag: net cash is negative after subtracting total debt, signaling potential liquidity constraints. Recent filings and transcripts do not disclose any material events or strategic initiatives that would significantly alter the company's financial trajectory in the near term. The company's financial disclosures remain consistent with its historical performance, with no indication of major operational or strategic shifts.
Key takeaways
  • Selic Corp PCL maintains a moderate debt-to-equity ratio of 0.85, indicating a balanced capital structure.
  • The company's return on equity of 3.99% and return on assets of 1.36% suggest suboptimal capital efficiency.
  • Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
  • Free cash flow of 67.083 million THB provides some operational flexibility but is constrained by capital expenditures.
  • The company's liquidity risk is rated as medium, with a key flag indicating negative net cash after debt.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$560.1M
Gross profit$175.1M
Operating income$96.3M
Net income$42.9M
R&D
SG&A
D&A
SBC
Operating cash flow$68.3M
CapEx-$21.1M
Free cash flow$67.1M
Total assets$3.15B
Total liabilities$2.08B
Total equity$1.08B
Cash & equivalents$193.1M
Long-term debt$919.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.45B$128.5M$81.5M$102.2M
FY-3$1.62B$78.3M$40.6M-$471.6M
FY-2$1.90B$205.2M$80.1M$52.9M
FY-1$2.13B$287.2M$127.6M$178.3M
FY0$2.04B$298.3M$147.1M$220.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.76B$668.1M$101.2M
FY-3$2.78B$957.5M$182.7M
FY-2$3.04B$1.03B$128.7M
FY-1$3.26B$1.17B$297.2M
FY0$3.21B$1.16B$325.9M
PeriodOCFCapExFCFSBC
FY-4$105.5M-$24.6M$102.2M
FY-3$128.5M-$569.5M-$471.6M
FY-2$172.9M-$136.2M$52.9M
FY-1$234.1M-$74.9M$178.3M
FY0$382.2M-$41.1M$220.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$560.1M$96.3M$42.9M$67.1M
FQ-6$504.7M$65.8M$30.4M$23.3M
FQ-5$513.4M$49.5M$20.9M$47.0M
FQ-4$553.6M$75.6M$33.5M$61.0M
FQ-3$551.8M$72.7M$34.9M$64.5M
FQ-2$489.9M$59.4M$29.4M$48.2M
FQ-1$488.7M$76.4M$38.4M$64.4M
FQ0$506.3M$89.9M$44.5M$66.6M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$3.15B$1.08B$193.1M
FQ-6$3.18B$1.09B$174.9M
FQ-5$3.32B$1.14B$368.4M
FQ-4$3.26B$1.17B$297.2M
FQ-3$3.34B$1.21B$350.2M
FQ-2$3.23B$1.21B$304.1M
FQ-1$3.18B$1.22B$299.9M
FQ0$3.21B$1.16B$325.9M
PeriodOCFCapExFCFSBC
FQ-7$68.3M-$21.1M$67.1M
FQ-6$171.1M-$60.9M$23.3M
FQ-5$196.2M-$64.5M$47.0M
FQ-4$234.1M-$74.9M$61.0M
FQ-3$114.0M-$4.9M$64.5M
FQ-2$228.9M-$14.6M$48.2M
FQ-1$281.3M-$23.3M$64.4M
FQ0$382.2M-$41.1M$66.6M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.08B
Net cash-$726.7M
Current ratio1.3
Debt/Equity0.8
ROA1.4%
ROE4.0%
Cash conversion1.6%
CapEx/Revenue-3.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricSELICActivity
Op margin17.2%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin7.7%4.1% medp25 0.1% · p75 8.8%above median
Gross margin31.3%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-3.8%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity85.0%37.1% medp25 10.3% · p75 82.0%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 02:11 UTC#7c101589
Market quoteclose THB 2.64 · shares 0.61B diluted
no public URL
2026-05-10 01:48 UTC#0dfa1930
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 09:13 UTCJob: ab894b94